Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc analysis of the JADE clinical trials

• প্রধান লেখক: Melinda J. Gooderham (লেখক), Michael R. Ardern‐Jones (লেখক), Emma Guttman‐Yassky (লেখক), Mahreen Ameen (লেখক), Eric L. Simpson (লেখক), Gary Chan (লেখক), Pinaki Biswas (লেখক), Wing S. Chiu (লেখক), Melissa Watkins (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Wiley, 2023-12-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background Patients with moderate‐to‐severe atopic dermatitis (AD) refractory to topical therapy might require treatment with systemic therapies, including biologics. Objectives To assess the efficacy and safety of abrocitinib monotherapy in patients who previously received systemic therapi...